SCHOTT Pharma AG & Co. KGaA (FRA: 1SXP)
Germany
· Delayed Price · Currency is EUR
23.72
+0.02 (0.08%)
At close: Dec 18, 2024
SCHOTT Pharma AG & Co. KGaA Revenue
In the fiscal year ending September 30, 2024, SCHOTT Pharma AG & Co. KGaA had annual revenue of 957.09M EUR with 6.51% growth. SCHOTT Pharma AG & Co. KGaA had revenue of 237.05M in the quarter ending September 30, 2024, with 3.73% growth.
Revenue
957.09M
Revenue Growth
+6.51%
P/S Ratio
n/a
Revenue / Employee
207.88K
Employees
4,646
Market Cap
3.66B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 957.09M | 58.49M | 6.51% |
Sep 30, 2023 | 898.60M | 77.46M | 9.43% |
Sep 30, 2022 | 821.14M | 172.48M | 26.59% |
Sep 30, 2021 | 648.67M | 64.44M | 11.03% |
Sep 30, 2020 | 584.23M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSCHOTT Pharma AG & Co. KGaA News
- 9 days ago - Schott Pharma carefully observing impact of Trump 2.0 on industry, says CEO - CNBC
- 9 days ago - SCHOTT Pharma Achieves Record Growth and Margins After Strong Year-End - Wallstreet:Online
- 9 days ago - EQS-News: SCHOTT Pharma with strong growth and record margin after solid year-end finish - Wallstreet:Online
- 17 days ago - EQS-News: Next-level efficiency and sustainability: SCHOTT Pharma unveils innovative nest design for ready-to-use cartridges - Wallstreet:Online